Provided by Tiger Trade Technology Pte. Ltd.

Ocugen

1.07
-0.2650-19.92%
Pre-market: 1.090.0235+2.21%09:25 EDT
Volume:39.26M
Turnover:43.70M
Market Cap:360.52M
PE:-4.18
High:1.32
Open:1.31
Low:1.06
Close:1.33
52wk High:2.73
52wk Low:1.03
Shares:338.52M
Float Shares:327.56M
Volume Ratio:12.86
T/O Rate:11.99%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2551
EPS(LYR):-0.2260
ROE:-660.00%
ROA:-48.44%
PB:-21.78
PE(LYR):-4.71

Loading ...

Ocugen Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 07

Ocugen, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Ocugen reports Q2 EPS (7c), consensus (5c)

TIPRANKS
·
Aug 06

Ocugen Q2 2026 earnings: Financing boosts cash while net loss widens

TradingKey
·
Aug 06

Ocugen Q2 FY26 Net Loss Widens to $24.88 Million; Revenue Rises to $1.49 Million

Reuters
·
Aug 06

Ocugen Q2 EPS USD -0.07

Reuters
·
Aug 06

Ocugen Q2 EPS $(0.07) Misses $(0.05) Estimate, Sales $1.488M Beat $888.833K Estimate

Benzinga Earnings
·
Aug 06

Ocugen Q2 Revenue USD 1.488 Million VS. Ibes Estimate USD 888.8 Thousand

THOMSON REUTERS
·
Aug 06

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Aug 06

Ocugen Inc Expected to Post a Loss of 5 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Aug 04

Ocugen Inc. Stock Falls Friday, Underperforms Market

Dow Jones
·
Aug 01

Ocugen to Present Modifier Gene Therapy Platform at Oppenheimer Biotech Summit

Reuters
·
Jul 31

Ocugen to Participate in Upcoming August Investor Conferences

GlobeNewswire
·
Jul 31

Ocugen Announces Special Shareholder Meeting

Reuters
·
Jul 31

Ocugen Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jul 30

Ocugen - to Initiate Ocu410 Phase 3 Trial in Q3 2026, Bla Filing Anticipated in 2028

THOMSON REUTERS
·
Jul 29

Ocugen Announces That the U.S. Food and Drug Administration Has Granted Ocu410 Regenerative Medicine Advanced Therapy (Rmat) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration

THOMSON REUTERS
·
Jul 29

Ocugen to Host Conference Call on Thursday, August 6 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2026 Financial Results

GlobeNewswire
·
Jul 29

Ocugen Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28